Here are what the editors at HealthDay consider to be the most important developments in Urology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Adjuvant Tx for Early Testicular Cancer Does Not Harm Sperm
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — For clinical stage I testicular cancer (TC) patients, adjuvant treatment after orchiectomy has no long-term significant effect on sperm production, according to a study published online Feb. 25 in the Annals of Oncology.
Stewardship Programs Decrease Inpatient Fluoroquinolone Rx
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — Fluoroquinolone stewardship interventions at hospitals are associated with less fluoroquinolone prescribing during hospitalization but not at discharge, according to a study published online Feb. 13 in Clinical Infectious Diseases.
2014 to 2017 Saw Improvement in Burnout for U.S. Physicians
MONDAY, Feb. 25, 2019 (HealthDay News) — From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.
National Health Spending Set to Increase 5.5 Percent Annually
FRIDAY, Feb. 22, 2019 (HealthDay News) — National health spending is projected to increase at an annual rate of 5.5. percent from 2018 to 2027, with fundamental economic and demographic factors the main drivers, according to a report published online Feb. 20 in Health Affairs.
FDA: Gout Drug Uloric Increases Risk of Death
FRIDAY, Feb. 22, 2019 (HealthDay News) — The gout medicine Uloric (febuxostat) carries a higher risk of death than allopurinol, according to the U.S. Food and Drug Administration.
Most Patients Do Not Disclose Complementary Medicine Use
FRIDAY, Feb. 22, 2019 (HealthDay News) — Just one-third of users of biologically based complementary medicine (CM) disclose their use to traditional health care providers, according to a review published online Feb. 7 in Scientific Reports.
Intervention Can Reduce Orders for Inpatient Urine Cultures
FRIDAY, Feb. 22, 2019 (HealthDay News) — An intervention that makes changes to urine testing orderables can reduce the urine culturing rate, according to a study published online Feb. 21 in Infection Control & Hospital Epidemiology.
Many Experience Improvement in Sex Life After Bariatric Surgery
THURSDAY, Feb. 21, 2019 (HealthDay News) — About half of women and men who report some level of dissatisfaction with their sexual life prior to bariatric surgery experience clinically meaningful improvement during five years of follow-up, according to a study published online Feb. 20 in JAMA Surgery.
Vertical Integration Has Little Impact on Quality Measures
THURSDAY, Feb. 21, 2019 (HealthDay News) — Vertical integration between hospitals and physicians has little impact on quality measures, while increased hospital market concentration is strongly associated with reduced quality in measures of patient satisfaction, according to a study published online Feb. 9 in Medical Care Research and Review.
Experimental Test May Quickly Diagnose Sepsis
WEDNESDAY, Feb. 20, 2019 (HealthDay News) — A blood test that can quickly diagnose dangerous sepsis infections has been developed, according to research published in the Feb. 1 issue of Biosensors and Bioelectronics.
New Kaiser Permanente Medical School Plans to Waive Tuition
WEDNESDAY, Feb. 20, 2019 (HealthDay News) — A new medical school to be opened by California-based health system Kaiser Permanente will waive tuition for all students in its first five graduating classes.
Plazomicin Noninferior to Meropenem for Complicated UTI
WEDNESDAY, Feb. 20, 2019 (HealthDay News) — Plazomicin is noninferior to meropenem for patients with complicated urinary tract infections (UTIs), according to a study and a research letter published in the Feb. 21 issue of the New England Journal of Medicine.
Black-White Cancer Mortality Gap Decreasing in Some Age Groups
WEDNESDAY, Feb. 20, 2019 (HealthDay News) — Cancer death rates are decreasing faster in blacks than whites in the United States, according to a report published online Feb. 14 in CA: A Cancer Journal for Clinicians.
Hospital Prices Growing Faster Than Physician Prices
FRIDAY, Feb. 15, 2019 (HealthDay News) — Growth in hospital prices and payments outpaced growth in physician prices and payments from 2007 through 2014, according to a report published in the February issue of Health Affairs.
Health Care Spending Per Person Increased to $5,641 in 2017
TUESDAY, Feb. 12, 2019 (HealthDay News) — In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report.
Many Systematic Reviews Do Not Fully Report Adverse Events
TUESDAY, Feb. 12, 2019 (HealthDay News) — Many systematic review protocols in the International Prospective Register of Systematic Reviews (PROSPERO) do not include adverse event reporting, according to a study published in the April issue of the Journal of Clinical Epidemiology.
Use of Watchful Waiting Up for Low-Risk Localized Prostate Cancer
TUESDAY, Feb. 12, 2019 (HealthDay News) — From 2010 to 2015, there was an increase in use of active surveillance or watchful waiting (AS/WW) rates in men with low-risk and intermediate-risk localized prostate cancer, according to a research letter published online Feb. 11 in the Journal of the American Medical Association.
Predictors of Kidney Stone Recurrence Identified
FRIDAY, Feb. 8, 2019 (HealthDay News) — A model has been developed for predicting recurrence among kidney stone formers, according to a study published in the February issue of the Mayo Clinic Proceedings.
Johnson & Johnson to Provide Drug Prices in TV Ads
FRIDAY, Feb. 8, 2019 (HealthDay News) — In a drug industry first, Johnson & Johnson will start giving the list prices of its prescription drugs in television ads.
Value-Based Incentive Program Does Not Cut Catheter-Linked UTIs
WEDNESDAY, Feb. 6, 2019 (HealthDay News) — Federal value-based incentive programs (VBIPs) are not associated with reductions in device-associated catheter-associated urinary tract infection (CAUTI) rates, according to a research letter published in the Feb. 5 issue of the Journal of the American Medical Association.
California Bill Would Tighten Controls on Children’s Genitalia Surgery
TUESDAY, Feb. 5, 2019 (HealthDay News) — A bill that would place more restrictions on children’s genitalia surgery in California raises serious concerns among doctors in the state. Under the bill, doctors would not be able to treat or perform surgery on children born with genitals that do not match a single gender or are otherwise atypical unless such surgery is medically necessary or the child consents, the Associated Press reported.
Copyright © 2019 ScoutNews, LLC. All rights reserved.